Mark Soto

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Acute Lymphoblastic Leukemia

Epidermal Growth Factor Receptor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Lindsay M Gurska, Rachel Okabe, Alexandra Schurer, Meng Maxine Tong, Mark Soto, Daniel C Choi, Kristina Ames, Shira G Glushakow-Smith, Allison Montoya, Ellen Tein, Linde A Miles, Haiying Cheng, Pamela A Hankey-Giblin, Ross L Levine, Swati Goel, Balazs Halmos, Kira Gritsman
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Lindsay M Gurska, Rachel Okabe, Alexandra Schurer, Meng Maxine Tong, Mark Soto, Daniel C Choi, Kristina Ames, Shira G Glushakow-Smith, Allison Montoya, Ellen Tein, Linde A Miles, Haiying Cheng, Pamela A Hankey-Giblin, Ross L Levine, Swati Goel, Balazs Halmos, Kira Gritsman
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Lindsay M Gurska, Rachel Okabe, Alexandra Schurer, Meng Maxine Tong, Mark Soto, Daniel C Choi, Kristina Ames, Shira G Glushakow-Smith, Allison Montoya, Ellen Tein, Linde A Miles, Haiying Cheng, Pamela A Hankey-Giblin, Ross L Levine, Swati Goel, Balazs Halmos, Kira Gritsman
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Lindsay M Gurska, Rachel Okabe, Alexandra Schurer, Meng Maxine Tong, Mark Soto, Daniel C Choi, Kristina Ames, Shira G Glushakow-Smith, Allison Montoya, Ellen Tein, Linde A Miles, Haiying Cheng, Pamela A Hankey-Giblin, Ross L Levine, Swati Goel, Balazs Halmos, Kira Gritsman
Crizotinib has Preclinical Efficacy in Philadelphia-negative Myeloproliferative Neoplasms. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)